Estrogen receptor α36 affects sensitivity of breast cancer cells to Herceptin

邓婷婷; 邹娇; 陈彬; 王杨; 姜晓梅; 王继红

您当前的位置：

首页 >

文章列表页 >

Estrogen receptor α36 affects sensitivity of breast cancer cells to Herceptin

更新时间：2026-01-09

- Estrogen receptor α36 affects sensitivity of breast cancer cells to Herceptin
- Journal of Army Medical University Vol. 37, Issue 11, Pages: 1080-1085(2015)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： R73-36;R737.9;R979.1
- Published：2015
- 稿件说明：
移动端阅览
邓婷婷,邹娇,陈彬,王杨,姜晓梅,王继红.ER-α36对乳腺癌细胞Herceptin敏感性的影响[J].陆军军医大学学报(原第三军医大学学报),2015,37(11):1080-1085.

　Deng Tingting,Zou Jiao,Chen Bin,Wang Yang,Jiang Xiaomei,Wang Jihong.Estrogen receptor α36 affects sensitivity of breast cancer cells to Herceptin[J].J Amry Med Univ (J Third Mil Med Univ),2015,37(11):1080-1085.
邓婷婷,邹娇,陈彬,王杨,姜晓梅,王继红.ER-α36对乳腺癌细胞Herceptin敏感性的影响[J].陆军军医大学学报(原第三军医大学学报),2015,37(11):1080-1085. DOI：

　Deng Tingting,Zou Jiao,Chen Bin,Wang Yang,Jiang Xiaomei,Wang Jihong.Estrogen receptor α36 affects sensitivity of breast cancer cells to Herceptin[J].J Amry Med Univ (J Third Mil Med Univ),2015,37(11):1080-1085. DOI：

摘要

目的探讨乳腺癌细胞中雌激素受体α36（estrogen receptor α36，ER-α36）对人表皮生长因子受体2（human epidermal growth factor receptor 2，HER2）人源化单克隆抗体赫赛汀（Herceptin）治疗敏感性的影响。方法 Western blot对G418筛选的BT474/ER-α36细胞和对照细胞BT474/V进行表型鉴定；细胞增殖分析观察常规培养条件下和雌二醇（E2）存在与否的条件下配对细胞对Herceptin敏感性的差异；Western blot检测Herceptin处理前后配对细胞中E2诱导的Akt及MAPK磷酸化差异。结果筛选并鉴定了ER-α36过表达的BT474/ER-α36细胞及对照细胞BT474/V；常规培养下，Herceptin 对BT474/ER-α36和BT474/V细胞的增殖抑制率分别为(22.00±0.06)%和(42.00±0.06)%，与对照细胞比较，BT474/ER-α36细胞对Herceptin的敏感性明显减弱（P0.01）；细胞经去类固醇处理后，在E2存在的情况下，Herceptin 对BT474/ER-α36和BT474/V细胞的增殖抑制率分别为（34.00±0.06)%和(53.00±0.06)%，E2显著降低了BT474/ER-α36对Herceptin的敏感性（P0.01）；BT474/ER-α36细胞E2诱导的HER2下游信号分子Akt和MAPK磷酸化水平分别上调了3.08倍和2.63倍，而BT474/V细胞E2诱导的Akt和MAPK磷酸化水平仅分别上调了2.37倍和1.72倍，与对照细胞比较，BT474/ER-α36细胞具有更强的E2非基因组活性，并且该细胞中Herceptin抑制Akt及MAPK磷酸化的效应明显减弱（P0.01）。结论 ER-α36可通过非基因组活性影响乳腺癌细胞Herceptin的敏感性。

Abstract

Objective To determine the effect of estrogen receptor α36 (ER-α36) on the sensitivity to Herceptin

a humanized monoclonal antibody directed against human epidermal growth factor receptor 2 (HER2)

in breast cancer cell lines. Methods G418 was used for the screening for ER-α36 over-expressing breast cancer cell line BT474/ER-α36 and control cell line BT474/V

and then the phenotype of the paired cells was identified by Western blotting. The sensitivity of the paired cells to Herceptin was observed in normal culture condition and in the presence or absence of estrogen (E2) by cell proliferation assay. Western blotting was used to detect the different phosphorylation levels of E2-induced Akt and MAPK in the paired cells before and after Heceptin treatment. Results ER-α36 over-expressing breast cancer cell line BT474/ER-α36 and control cell line BT474/V had been screened successfully. In normal culture condition

the inhibitory ratio of Herceptin on the proliferation of BT474/ER-α36 and BT474/V cells was (22.00±0.06)% and (42.00±0.06)%

respectively

indicating that the sensitivity of BT474/ER-α36 cells to Herceptin was obviously attenuated

compared with control cells (P0.01). In the presence of E2

the inhibitory ratio of Herceptin on the proliferation of BT474/ER-α36 and BT474/V cells deprived of steroid hormones was (34.00±0.06)% and (53.00±0.06)%

respectively

indicating that E2 significantly decreases the sensitivity of BT474/ER-α36 cells to Herceptin. E2-induced phosphorylation of Akt or MAPK

a downstream molecule of HER2 pathway

was up-regulated over 3.08 fold or 2.63 fold

in BT474/ER-α36 cells

but only was up-regulated over 2.37 fold or 1.72 fold

in BT474/V cells. Compared with BT474/V control cells

the higher E2-induced ERα-36 non genomic activities and the weaker inhibition of phosphorylation of Akt and MAPK caused by Herceptin were found in BT474/ER-α36 cells (P0.01). Conclusion ER-α36 can affect the sensitivity of breast cancer cells to Herceptin through non-genomic activity.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

A novel estrogen receptor expression stratification (low/moderate/high) based on Chinese population provides more accurate prognosis prediction for HR⁺/HER2^- early breast cancer patients

Downregulating RRM2B expression to increase radiation sensitivity of breast cancer cells

Characteristics of body image and their relationship with perceived stress, self-compassion and implicit attitudes in female breast cancer patients

Prognostic factors for breast cancer brain metastasis and primary construction of a prediction model

LINC00294 promotes proliferation, invasion, and migration of breast cancer cells via AKT/mTOR/HIF-1α pathway

Related Author

WANG Chengfang

ZHOU Yuqin

ZHANG Yanling

QI Xiaowei

ZHANG Yi

李安琪

孙海燕

祁孟瑶

Related Institution

Department of Breast and Thyroid Surgery， First Affiliated Hospital， Army Medical University （Third Military Medical University）

⁰